ELV Quote, Financials, Valuation and Earnings

Centene Corp. has a net margin of 2.34% compared to Elevance Health, Inc.'s net margin of -13.35%. Elevance Health, Inc.'s return on equity of 12.81% beat Centene Corp.'s return on equity of -20.3%.

Elevance Health, Inc. has a consensus price target of $387.16, signalling upside risk potential of 17.06%. On the other hand Centene Corp. has an analysts' consensus of $39.94 which suggests that it could grow by 2.92%. Given that Elevance Health, Inc. has higher upside potential than Centene Corp., analysts believe Elevance Health, Inc. is more attractive than Centene Corp..

Elevance Health, Inc. has a beta of 0.522, which suggesting that the stock is 47.789% less volatile than S&P 500. In comparison Centene Corp. has a beta of 0.476, suggesting its less volatile than the S&P 500 by 52.425%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 2.03%. Centene Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 25.39% of its earnings as a dividend. Centene Corp. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $50.7B, which are larger than Centene Corp. quarterly revenues of $49.7B. Elevance Health, Inc.'s net income of $1.2B is higher than Centene Corp.'s net income of -$6.6B. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.64x while Centene Corp.'s PE ratio is 8.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.10x for Centene Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare, Inc. has a net margin of 2.34% compared to Elevance Health, Inc.'s net margin of 0.69%. Elevance Health, Inc.'s return on equity of 12.81% beat Molina Healthcare, Inc.'s return on equity of 19.74%.

Elevance Health, Inc. has a consensus price target of $387.16, signalling upside risk potential of 17.06%. On the other hand Molina Healthcare, Inc. has an analysts' consensus of $170.00 which suggests that it could grow by 14.03%. Given that Elevance Health, Inc. has higher upside potential than Molina Healthcare, Inc., analysts believe Elevance Health, Inc. is more attractive than Molina Healthcare, Inc..

Elevance Health, Inc. has a beta of 0.522, which suggesting that the stock is 47.789% less volatile than S&P 500. In comparison Molina Healthcare, Inc. has a beta of 0.516, suggesting its less volatile than the S&P 500 by 48.37%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 2.03%. Molina Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 25.39% of its earnings as a dividend. Molina Healthcare, Inc. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $50.7B, which are larger than Molina Healthcare, Inc. quarterly revenues of $11.5B. Elevance Health, Inc.'s net income of $1.2B is higher than Molina Healthcare, Inc.'s net income of $79M. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.64x while Molina Healthcare, Inc.'s PE ratio is 9.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.18x for Molina Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of 2.34% compared to Elevance Health, Inc.'s net margin of -4.6%. Elevance Health, Inc.'s return on equity of 12.81% beat Oscar Health, Inc.'s return on equity of -21.36%.

Elevance Health, Inc. has a consensus price target of $387.16, signalling upside risk potential of 17.06%. On the other hand Oscar Health, Inc. has an analysts' consensus of $14.38 which suggests that it could fall by -15.94%. Given that Elevance Health, Inc. has higher upside potential than Oscar Health, Inc., analysts believe Elevance Health, Inc. is more attractive than Oscar Health, Inc..

Elevance Health, Inc. has a beta of 0.522, which suggesting that the stock is 47.789% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 2.03%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Elevance Health, Inc. pays 25.39% of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $50.7B, which are larger than Oscar Health, Inc. quarterly revenues of $3B. Elevance Health, Inc.'s net income of $1.2B is higher than Oscar Health, Inc.'s net income of -$137.5M. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.64x while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.40x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of 2.34% compared to Elevance Health, Inc.'s net margin of 2.25%. Elevance Health, Inc.'s return on equity of 12.81% beat UnitedHealth Group, Inc.'s return on equity of 17.57%.

Elevance Health, Inc. has a consensus price target of $387.16, signalling upside risk potential of 17.06%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $388.52 which suggests that it could grow by 14.37%. Given that Elevance Health, Inc. has higher upside potential than UnitedHealth Group, Inc., analysts believe Elevance Health, Inc. is more attractive than UnitedHealth Group, Inc..

Elevance Health, Inc. has a beta of 0.522, which suggesting that the stock is 47.789% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.428, suggesting its less volatile than the S&P 500 by 57.182%.

Elevance Health, Inc. has a quarterly dividend of $1.71 per share corresponding to a yield of 2.03%. UnitedHealth Group, Inc. offers a yield of 2.54% to investors and pays a quarterly dividend of $2.21 per share. Elevance Health, Inc. pays 25.39% of its earnings as a dividend. UnitedHealth Group, Inc. pays out 52.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Elevance Health, Inc. quarterly revenues are $50.7B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Elevance Health, Inc.'s net income of $1.2B is lower than UnitedHealth Group, Inc.'s net income of $2.5B. Notably, Elevance Health, Inc.'s price-to-earnings ratio is 13.64x while UnitedHealth Group, Inc.'s PE ratio is 17.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Elevance Health, Inc. is 0.39x versus 0.71x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.